Boston, MA 10/08/2014 (wallstreetpr) – The stock of ARMSTRONG, Iowa headquartered equipment manufacturer Arts-Way Manufacturing Co. Inc. (NASDAQ:ARTW) surged upwards yesterday after it reported strong results from its 3Q14 operations. The results pertained to quarter period which ended on August 31, 2014. The firm reported that its net sales were up 23.9 percent to reach $11.58 million, while operating income reached $ 908,000 and was up by a stupendous 1581.5 percent during the reporting quarter, in comparison to 3Q13. Net income came in at $558,000, which was up by 2046.2 percent in 3Q14 as against 3Q13. The firm has also scheduled an interaction with the press on October 9, 2014 during which time, company Chairman of the Board of Directors J. Ward McConnell, Jr would take questions from the press and the analyst community.
Biotechnology firm RXi Pharmaceuticals Corp (NASDAQ:RXII) released data on 7th October from Phase 2a clinical tests conducted on its clinical drug candidate RXI-109. The data related to tests conducted on two registered patients have indicated that hypertrophic scars could be treated effectively over a three month period. The drug maker also indicated that it would continue to monitor the patients for the next 9 months to complete the trail. RXi Pharmaceuticals Corp (NASDAQ:RXII) had reported in the first week of September that it was fine tuning dosing in order to accelerate the treatment optimization process. Stock price of the drug firm surged yesterday after the release of positive data.
Investors in the shares of solar energy-electricity equipment installer Vivint Solar Holdings Inc (NYSE:VSLR) recouped part of the losses they had incurred ever since the stock started trading last week. The stock had commenced trading at the initial public offering price of $17.01 per share on 1st October. “Residential-solar installer operations” had been hived off by “home security and automation” company Vivint Inc. Vivint Solar Holdings Inc (NYSE:VSLR) CEO, Greg Butterfield has indicated that they would attempt to tap into the existing customer base of its parent company to win new business.